Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
Ethicon, Inc.
National Cancer Institute (NCI)
Pfizer
Ethicon, Inc.
Mayo Clinic
University of Kentucky
Tempus AI
Washington University School of Medicine
Massachusetts General Hospital
NRG Oncology
ImmunoGenesis
University of Kentucky
Faeth Therapeutics
NextCure, Inc.
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute
Bristol-Myers Squibb
Elevation Oncology
Fundación GECP
Checkpoint Therapeutics, Inc.
NantCell, Inc.
Emory University
NantCell, Inc.
Georgetown University
Pfizer
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Olympus Corporation of the Americas
Washington University School of Medicine
Spanish Lung Cancer Group
Wake Forest University Health Sciences
Sumitomo Pharma America, Inc.
Rutgers, The State University of New Jersey
pharmaand GmbH
The Methodist Hospital Research Institute
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Syndax Pharmaceuticals
University of Washington
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
G1 Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
AIDS Malignancy Consortium